


Healthcare News Roundup: Oncology
HSMN NewsFeed - 2 Jan 2014
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
HSMN NewsFeed - 24 Dec 2013
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
HSMN NewsFeed - 24 Dec 2013
Atossa Genetics Submits Premarket 510(k) Notification for ForeCYTE Breast Aspirator
Atossa Genetics Submits Premarket 510(k) Notification for ForeCYTE Breast Aspirator
HSMN NewsFeed - 23 Dec 2013
RaySearch Laboratories: ProCure Proton Centers Select RayStation(R) for Proton Planning
RaySearch Laboratories: ProCure Proton Centers Select RayStation(R) for Proton Planning
HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
HSMN NewsFeed - 19 Dec 2013
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors
HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
HSMN NewsFeed - 18 Dec 2013
Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan
Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan
HSMN NewsFeed - 17 Dec 2013
Pfizer Names Albert Bourla Group President, Vaccines, Oncology and Consumer Healthcare Business
Pfizer Names Albert Bourla Group President, Vaccines, Oncology and Consumer Healthcare Business
HSMN NewsFeed - 17 Dec 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
HSMN NewsFeed - 17 Dec 2013
ViewRay(TM) Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System
ViewRay(TM) Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System
HSMN NewsFeed - 17 Dec 2013
Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware
Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware
HSMN NewsFeed - 13 Dec 2013
Nucletron, an Elekta company, Installs Esteya for Treating Skin Cancer in Major US Center
Nucletron, an Elekta company, Installs Esteya for Treating Skin Cancer in Major US Center
HSMN NewsFeed - 9 Dec 2013
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
LabCorp to Offer the IntelliGENTM Multi-Gene Oncology Panel on the Next Generation Sequencing Platform
HSMN NewsFeed - 4 Dec 2013
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
HSMN NewsFeed - 4 Dec 2013
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI(R) (pixantrone) in Germany
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI(R) (pixantrone) in Germany
HSMN NewsFeed - 27 Nov 2013
Elekta Receives US FDA 510(k) Clearance for its Monaco 5 Treatment Planning System
Elekta Receives US FDA 510(k) Clearance for its Monaco 5 Treatment Planning System
HSMN NewsFeed - 20 Nov 2013
ImmunoGen, Inc. Announces Approval of Roche’s Kadcyla(R) in the European Union
ImmunoGen, Inc. Announces Approval of Roche’s Kadcyla(R) in the European Union
HSMN NewsFeed - 19 Nov 2013
South Korea’s Yonsei University Health System orders four Elekta radiation therapy systems
South Korea’s Yonsei University Health System orders four Elekta radiation therapy systems
